Jessica Henderson, NP
Family · San Antonio, TXNPI 1588204077
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 81 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,110, more than ten times the $26 reported in 2023.
Across 81 payments — averaging $16.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$245
- AbbVie$200
- Abiomed$154
- Johnson & Johnson$109
- Grifols USA, LLC$97
- Biogen$81
- plus $420 from 15 others
What the payments were for
- Food & beverage$1,306100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 32 | $245 |
| AbbVie | 17 | $200 |
| Abiomed | 3 | $154 |
| Johnson & Johnson(2 entities) | 4 | $109 |
| Grifols USA, LLC | 3 | $97 |
| Biogen | 3 | $81 |
| Genentech USA, Inc. | 3 | $54 |
| EMD Serono, Inc. | 2 | $52 |
| Lilly USA, LLC | 2 | $49 |
| AstraZeneca | 1 | $35 |
| Neurocrine Biosciences, Inc. | 1 | $30 |
| Argenx US, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $27 |
| UCB, Inc. | 1 | $24 |
| Novartis | 1 | $23 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| Ipsen Biopharmaceuticals, Inc | 1 | $18 |
| Livanova USA, Inc. | 1 | $16 |
| Gilead | 1 | $16 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Pfizer | 1 | $13 |
How this compares
$1,306 in reported general payments places this provider in the 70th percentile of 15,456 family providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family in San Antonio
- Anna CastroSan Antonio$184K
- Natalia FariasSan Antonio$124K
- Tina CoppleSan Antonio$97K
- Kim HinojosaSan Antonio$63K
- Kimberly GibergaSan Antonio$36K
- Febbie PhiriSan Antonio$31K
- Annette GantzSan Antonio$31K
- Renee ChisumSan Antonio$28K
- Thimios PartalasSan Antonio$27K
- David WeirDallas$959K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.